1999
DOI: 10.1093/carcin/20.4.569
|View full text |Cite
|
Sign up to set email alerts
|

Sustained phospholipase D activation is associated with keratinocyte differentiation

Abstract: Our previous results and data in the literature have suggested a potential role for phospholipase D (PLD) in the regulation of epidermal keratinocyte growth and differentiation. Therefore, we investigated the effect of agents reported to modulate keratinocyte growth and differentiation on PLD activation. The purported protein kinase C (PKC) 'inhibitor', staurosporine (Stsp), has been reported to activate PKC in keratinocytes, eliciting many of the same effects as active tumor promoters such as 12-Otetradecanoy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
19
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 23 publications
2
19
0
Order By: Relevance
“…We determined the ability of FIPI, an agent that inhibits both PLD1 and PLD2 ( 26 ), to inhibit PLD activity in intact keratinocytes by measuring the effect of FIPI pretreatment on PLD activation in response to the phorbol ester, 12-O -tetradecanoylphorbol 13-acetate (TPA). As shown previously ( 27 ), TPA stimulated PLD activity in keratinocytes, as measured by an approximate 4.5-fold increase in radiolabeled PEt levels ( Fig. 7 ).…”
Section: Effect Of Wounding-induced Pld Activation On Pg Levelssupporting
confidence: 87%
“…We determined the ability of FIPI, an agent that inhibits both PLD1 and PLD2 ( 26 ), to inhibit PLD activity in intact keratinocytes by measuring the effect of FIPI pretreatment on PLD activation in response to the phorbol ester, 12-O -tetradecanoylphorbol 13-acetate (TPA). As shown previously ( 27 ), TPA stimulated PLD activity in keratinocytes, as measured by an approximate 4.5-fold increase in radiolabeled PEt levels ( Fig. 7 ).…”
Section: Effect Of Wounding-induced Pld Activation On Pg Levelssupporting
confidence: 87%
“…Subsequently, [ 3 H]thymidine (1 Ci/ml final concentration) was added, and the cells were incubated an additional 60 min. The radioactivity in 5% trichloroacetic acid-precipitable DNA was then quantified by liquid scintillation spectroscopy, following washing and solubilization in 0.3 M NaOH as in Jung et al (1999).…”
Section: Methodsmentioning
confidence: 99%
“…Keratinocytes were incubated for 24 h in SFKM containing the appropriate agents. After the cells were scraped into homogenization buffer [0.1 M Tris-acetate, pH 7.8, 2 g/ml aprotinin, 2 M leupeptin, 1 M pepstatin A, 0.2 mM EDTA, and 20 M 4-(2-aminoethyl)benzenesulfonyl fluoride] and subjected to one freeze-thaw cycle, transglutaminase activity was determined by monitoring the incorporation of [ 3 H]putrescine into casein as described in Jung et al (1999).…”
Section: Methodsmentioning
confidence: 99%
“…Inhibitor concentrations were selected based on previous data from our laboratory Shapiro et al, 2002), and all samples contained the same concentration of vehicle (dimethyl sulfoxide; DMSO). Phospholipids were extracted with chloroform/methanol and separated by thin layer chromatography as described in Jung et al (1999). Radiolabeled phosphatidylethanol, a unique marker of PLD activity (Thompson et al, 1991), was quantified by liquid scintillation spectrometry, also as described in Jung et al (1999).…”
Section: Materials the Pkc Inhibitors Romentioning
confidence: 99%
“…Phospholipids were extracted with chloroform/methanol and separated by thin layer chromatography as described in Jung et al (1999). Radiolabeled phosphatidylethanol, a unique marker of PLD activity (Thompson et al, 1991), was quantified by liquid scintillation spectrometry, also as described in Jung et al (1999).…”
Section: Materials the Pkc Inhibitors Romentioning
confidence: 99%